Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study

Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study

BK virus-associated nephropathy (PvAN) increases the risk of graft failure justifying treatment. Conversion to mammalian target of rapamycin inhibitors (mTORi) and Human polyclonal immunoglobulins (IVIg) could prevent the risk of PvAN. Our retrospective study assessed the efficacy of mTORi associate...

Full description

Bibliographic Details
Main Authors: Carla Vela, Thomas Jouve, Eloi Chevallier, Farida Imerzoukene, Raphaële Germi, Marion Le Marechal, Aurélie Truffot, Gaëlle Fiard, Bénédicte Janbon, Diane Giovannini, Paolo Malvezzi, Lionel Rostaing, Johan Noble
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Journal of Clinical Medicine
Subjects:
BK virus infection
mTOR inhibitors
renal transplantation
Online Access:https://www.mdpi.com/2077-0383/11/24/7292

Internet

https://www.mdpi.com/2077-0383/11/24/7292

Similar Items